MedPath
Found 1 clinical trials|View Analysis
Sort by:

Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia

Phase 2
Completed
Conditions
Acute Undifferentiated Leukemia
Acute Leukemia of Ambiguous Lineage
Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified
Mixed Phenotype Acute Leukemia
Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified
Acute Bilineal Leukemia
Acute Biphenotypic Leukemia
Recurrent Mixed Phenotype Acute Leukemia
Interventions
First Posted Date
2014-05-12
Last Posted Date
2024-03-22
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
16
Registration Number
NCT02135874
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath